Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study)

To achieve global hepatitis elimination by 2030, it is critical to prevent the mother-to-child transmission (MTCT) of hepatitis B virus (HBV). Since 2009, the WHO has recommended administering hepatitis B vaccine to all neonates within 24 h of birth to prevent MTCT. However, many countries in sub-Sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tall, Haoua, Adam, Pierrick, Tiendrebeogo, Abdoul Salam Eric, Vincent, Jeanne Perpétue, Schaeffer, Laura, von Platen, Cassandre, Fernandes-Pellerin, Sandrine, Sawadogo, François, Bokoum, Alkadri, Bouda, Ghislain, Ouattara, Seydou, Ouédraogo, Issa, Herrant, Magali, Boucheron, Pauline, Sawadogo, Appolinaire, Betsem, Edouard, Essoh, Alima, Kabore, Lassané, Ouattara, Amariane, Méda, Nicolas, Hien, Hervé, Gosset, Andréa, Giles-Vernick, Tamara, Boyer, Sylvie, Kania, Dramane, Vray, Muriel, Shimakawa, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227098/
https://www.ncbi.nlm.nih.gov/pubmed/34206058
http://dx.doi.org/10.3390/vaccines9060583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227098/
https://www.ncbi.nlm.nih.gov/pubmed/34206058
http://dx.doi.org/10.3390/vaccines9060583

Ejemplares similares